نتایج جستجو برای: pegasys

تعداد نتایج: 54  

2014
BO ZHANG MINTAO HU LIHUA HUANG YUNCHUAN PU HAO PEI ZHONG HUA SHANGZHI YAO

The aim of the present study was to observe the effects of Fuzheng Huayu capsule combined with Pegasys (peginterferon α-2a) on hepatic fibrosis in rats and in the treatment of patients with genotype 1 hepatitis C and hepatic cirrhosis. A dimethylnitrosamine (DMN)-induced rat model of liver injury was established. Fuzheng Huayu capsule combined with Pegasys was administered to the rats and the D...

2012
C-C Chen P-C Wang H-W Chang C-F Chen

The focus of this study was to evaluate the safety and efficacy of sequential peginterferon α-2a (Pegasys) therapy for chronic hepatitis B with acute exacerbation [ALT > 10 × upper limit of normal (ULN), bilirubin <2.0 mg/dL]. Four groups of patients categorized by HBeAg status and treatment regimens were studied since May 2007. Nineteen HBeAg-positive patients (Group 1) had received entecavir ...

Journal: :gastroenterology and hepatology from bed to bench 0
mostafa alavi-moghaddam seyed-moayed alavian bashir hajibeigi

aim : the aim of study was to determine the preliminary result of treatment with pegasys in iranian chronic hepatitis b patients (with genotype d) referred to tehran hepatitis center (thc). background : the genotype of hbv and ethnicity of the patients can affect the response rate to pegasys. patients and methods : during 2006-2008, 12 patients with naïve chronic hepatitis b (genotype d) that r...

2010
Maria Grazia Rumi Antonio Ascione

Pegylated interferon plus weight-adjusted ribavirin is standard therapy for chronic hepatitis C, but there has not been consensus about the relative benefits of Pegasys (Roche/Genentech) and PegInton (Schering-Plough). Past research has produced conflicting findings, and data have not always been strictly comparable due to regimen differences such as varying doses of ribavirin, which helps prev...

Journal: :Bioconjugate chemistry 2013
Ta-Chun Cheng Kuo-Hsiang Chuang Michael Chen Hsin-Ell Wang Shey-Cherng Tzou Yu-Cheng Su Chih-Hung Chuang Chien-Han Kao Bing-Mae Chen Long-Sen Chang Steve R Roffler Tian-Lu Cheng

Attachment of poly(ethylene glycol) to proteins can mask immune epitopes to increase serum half-life, reduce immunogenicity, and enhance in vivo biological efficacy. However, PEGylation mediated epitope-masking may also limit sensitivity and accuracy of traditional ELISA. We previously described an anti-PEG-based sandwich ELISA for universal assay of PEGylated molecules. Here, we compared the q...

2016
Sojan Abraham Jang-Gi Choi Nora M. Ortega Junli Zhang Premlata Shankar N. Manjunath Swamy

Because endogenous interferon type I (IFN-I) produced by HIV-1 infection might complicate the analysis of therapeutically administered IFN-I, we tested different humanized mouse models for induction of IFN-I during HIV-1 infection. While HIV-1 induced high levels of IFN-α in BLT mice, IFN-I was undetectable following infection in the Hu-PBL mouse model, in which only T cells expand. We therefor...

1990
S. Shuvalov

I estimate rates for cumulative particle production from C, Ca and Pb nuclei for conditions of Fermilab experiment E665 of p-A deep inelastic scattering. Estimates have been obtained on the basis of hadron-nuclei interactions experimental data. The possibility of also detecting backward produced charged particles by liquid scintillator neutron counters is discussed. This experiment, to be run i...

Journal: :Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie 2005
C C Vere Carmen Avrămescu L Mogoantă I Rogoveanu S Cazacu T Ciurea

Hepatitis C virus infection can cause progressive liver injury and lead to fibrosis and eventually cirrhosis. Peginterferon alfa-2a represents a significant advance in the treatment of patients with chronic hepatitis C. The aim of the study was to investigate the efficacy, safety and tolerability of the therapy with Peginterferon alfa-2a plus Ribavirin in patients with chronic hepatitis C. The ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید